Multiscale biased chemical space remodeling for developing APLNR agonists with anti-HFpEF efficacy

Heart failure with preserved ejection fraction (HFpEF) represents a significant global health burden, yet effective pharmacotherapies remain elusive. The angiotensin-like 1 receptor, also known as the apelin receptor (APLNR), is a promising target for treating HFpEF due to its role in modulating cardiovascular function. Despite the cardioprotective effects of endogenous ligand, apelin, achieving G-protein-biased agonism for therapeutic benefit poses a significant challenge. In this study, we unravel the biased signal transduction pathway mediated by a reported partial G<sub>i</sub>-protein-biased APLNR agonist CMF-019 and developed a biased chemical space remodeling approach to identify exclusive G-protein-biased agonists targeting APLNR. These agonists exhibited enhanced Gi-protein-biased function and protective effects in both in vitro and in vivo. Our findings not only enhance comprehension of APLNR-biased agonism but also establish drug design strategies for modifying and reshaping biased chemical landscapes in other G-protein-coupled receptors (GPCRs).

Authors

Institutions

Publication Details

Journal
Proceedings of the National Academy of Sciences
Published
2025-05-02
DOI
https://doi.org/10.1073/pnas.2423432122
Citations
1
Primary Topic
Apelin-related biomedical research
Type
article
Field-Weighted Citation Impact
1.39

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Multiscale biased chemical space remodeling for developing APLNR agonists with anti-HFpEF efficacy

Zhenhua Shao, Liang Ouyang, Yuying Feng, Yan Deng et al.
1 citations
Proceedings of the National Academy of Sciences
Apelin-related biomedical research
1.39
article

Multiscale biased chemical space remodeling for developing APLNR agonists with anti-HFpEF efficacy

Zhenhua Shao, Liang Ouyang, Yuying Feng, Yan Deng, Yixiao Xiong, Qiu Sun, Wei Yan, Yingqiang Guo, Tao Li, Lun Tan, Lele Zhang, Yujia Wang, Xiaowen Tian, Jiayi Zhu, Huan Xiao, Sicen Liu
article en
1 citations

Abstract

Heart failure with preserved ejection fraction (HFpEF) represents a significant global health burden, yet effective pharmacotherapies remain elusive. The angiotensin-like 1 receptor, also known as the apelin receptor (APLNR), is a promising target for treating HFpEF due to its role in modulating cardiovascular function. Despite the cardioprotective effects of endogenous ligand, apelin, achieving G-protein-biased agonism for therapeutic benefit poses a significant challenge. In this study, we unravel the biased signal transduction pathway mediated by a reported partial G<sub>i</sub>-protein-biased APLNR agonist CMF-019 and developed a biased chemical space remodeling approach to identify exclusive G-protein-biased agonists targeting APLNR. These agonists exhibited enhanced Gi-protein-biased function and protective effects in both in vitro and in vivo. Our findings not only enhance comprehension of APLNR-biased agonism but also establish drug design strategies for modifying and reshaping biased chemical landscapes in other G-protein-coupled receptors (GPCRs).

Proceedings of the National Academy of SciencesVol. 122(18)
Shanghai University (CN), Sichuan University (CN), West China Hospital of Sichuan University (CN), State Key Laboratory of Biotherapy
National Natural Science Foundation of China
Good health and well-being
Openalex Percentile: Top 21%
Apelin-related biomedical research
1.39
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.